Azopt

Generic: brinzolamide

Labeler: Novartis Pharmaceuticals Corporation
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive

Drug Facts

Product Profile

Brand Name Azopt
Generic Name brinzolamide
Labeler Novartis Pharmaceuticals Corporation
Dosage Form SUSPENSION/ DROPS
Routes
OPHTHALMIC
Active Ingredients

BRINZOLAMIDE 10 mg/mL

Identifiers & Regulatory

Product NDC 0078-0722
Product ID 0078-0722_c1d78ba6-3007-4423-8b0f-b81f9cc5e6f6
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA020816
Marketing Start 1998-04-30
Marketing End 2026-02-28

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00780722
Hyphenated Format 0078-0722

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name Azopt (source: ndc)
Generic Name brinzolamide (source: ndc)
Application Number NDA020816 (source: ndc)
Routes
OPHTHALMIC
source: ndc

Resolved Composition

Strengths
  • 10 mg/mL
source: ndc
Packaging
  • 1 BOTTLE in 1 CARTON (0078-0722-10) / 10 mL in 1 BOTTLE
source: ndc

Packages (1)

0078-0722-10 1 BOTTLE in 1 CARTON (0078-0722-10) / 10 mL in 1 BOTTLE

Ingredients (1)

BRINZOLAMIDE (10 mg/mL)

Linked Drug Pages (1)

Azopt ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["OPHTHALMIC"], "spl_id": "c1d78ba6-3007-4423-8b0f-b81f9cc5e6f6", "openfda": {"nui": ["N0000175517", "N0000000235"], "unii": ["9451Z89515"], "rxcui": ["213272", "308805"], "spl_set_id": ["acc89925-3ee3-4632-98ae-38a546848346"], "pharm_class_epc": ["Carbonic Anhydrase Inhibitor [EPC]"], "pharm_class_moa": ["Carbonic Anhydrase Inhibitors [MoA]"], "manufacturer_name": ["Novartis Pharmaceuticals Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (0078-0722-10)  / 10 mL in 1 BOTTLE", "package_ndc": "0078-0722-10", "marketing_end_date": "20260228", "marketing_start_date": "20211224"}], "brand_name": "Azopt", "product_id": "0078-0722_c1d78ba6-3007-4423-8b0f-b81f9cc5e6f6", "dosage_form": "SUSPENSION/ DROPS", "pharm_class": ["Carbonic Anhydrase Inhibitor [EPC]", "Carbonic Anhydrase Inhibitors [MoA]"], "product_ndc": "0078-0722", "generic_name": "brinzolamide", "labeler_name": "Novartis Pharmaceuticals Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Azopt", "active_ingredients": [{"name": "BRINZOLAMIDE", "strength": "10 mg/mL"}], "application_number": "NDA020816", "marketing_category": "NDA", "marketing_end_date": "20260228", "marketing_start_date": "19980430"}